A method for Boolean analysis of protein interactions at a molecular level.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
13 08 2022
Historique:
received: 01 07 2021
accepted: 29 07 2022
entrez: 13 8 2022
pubmed: 14 8 2022
medline: 17 8 2022
Statut: epublish

Résumé

Determining the levels of protein-protein interactions is essential for the analysis of signaling within the cell, characterization of mutation effects, protein function and activation in health and disease, among others. Herein, we describe MolBoolean - a method to detect interactions between endogenous proteins in various subcellular compartments, utilizing antibody-DNA conjugates for identification and signal amplification. In contrast to proximity ligation assays, MolBoolean simultaneously indicates the relative abundances of protein A and B not interacting with each other, as well as the pool of A and B proteins that are proximal enough to be considered an AB complex. MolBoolean is applicable both in fixed cells and tissue sections. The specific and quantifiable data that the method generates provide opportunities for both diagnostic use and medical research.

Identifiants

pubmed: 35963857
doi: 10.1038/s41467-022-32395-w
pii: 10.1038/s41467-022-32395-w
pmc: PMC9375095
doi:

Substances chimiques

Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4755

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

Fields, S. & Song, O. A novel genetic system to detect protein - protein interactions. Lett. Nat. 340, 245–246 (1989).
doi: 10.1038/340245a0
Petschnigg, J. et al. The mammalian-membrane two-hybrid assay (mamth) for probing membrane-protein interactions in human cells. Artic. Nat. Methods 11, 585 (2014).
doi: 10.1038/nmeth.2895
Hu, C.-D., Chinenov, Y. & Kerppola, T. K. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell 9, 789–798 (2002).
pubmed: 11983170 doi: 10.1016/S1097-2765(02)00496-3
Nguyen, A. W. & Daugherty, P. S. Evolutionary optimization of fluorescent proteins for intracellular FRET. Nat. Biotechnol. 3, 355–360 (2005).
doi: 10.1038/nbt1066
Edelhoch, H., Brand, L. & Wilchek, M. Fluorescence studies with tryptophyl peptides. Biochemistry 6, 547–559 (1967).
pubmed: 6047638 doi: 10.1021/bi00854a024
Stryer, L. & Haugland, R. P. Energy transfer: a spectroscopic ruler. Proc. Natl Acad. Sci. USA 58, 719–726 (1967).
pubmed: 5233469 pmcid: 335693 doi: 10.1073/pnas.58.2.719
Leavesley, S. J. & Rich, T. C. Overcoming limitations of FRET measurements. Cytom. Part A 89, 325–327 (2016).
doi: 10.1002/cyto.a.22851
Bastiaens, P. I. H. & Jovin, T. M. Microspectroscopic imaging tracks the intracellular processing of a signal transduction protein: fluorescent-labeled protein kinase C βI. Proc. Natl Acad. Sci. USA 93, 8407–8412 (1996).
pubmed: 8710884 pmcid: 38684 doi: 10.1073/pnas.93.16.8407
Söderberg, O. et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995–1000 (2006).
pubmed: 17072308 doi: 10.1038/nmeth947
Klaesson, A. et al. Improved efficiency of in situ protein analysis by proximity ligation using UnFold probes. Sci. Rep. 8, 1–13 (2018).
doi: 10.1038/s41598-018-23582-1
Koos, B. et al. Proximity-dependent initiation of hybridization chain reaction. Nat. Commun. 6, 7294 (2015).
Ray, R. M., Vaidya, R. J. & Johnson, L. R. MEK/ERK regulates adherens junctions and migration through Rac1. Cell Motil. Cytoskeleton 64, 143–156 (2007).
pubmed: 17183546 doi: 10.1002/cm.20172
Horiguchi, Y., Furukawa, F., Fujita, M. & Imamura, S. Ultrastructural localization of E-cadherin cell adhesion molecule on the cytoplasmic membrane of keratinocytes in vivo and in vitro. J. Histochem. Cytochem. 42, 1333–1340 (1994).
pubmed: 7930515 doi: 10.1177/42.10.7930515
Bateman, A. et al. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 49, D480–D489 (2021).
doi: 10.1093/nar/gkaa1100
Huber, A. H. & Weis, W. I. The structure of the b-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by b-catenin. Cell 105, 391–402 (2001).
Uhlén, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).
Dechat, T. et al. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev. 22, 832–853 (2008).
pubmed: 18381888 pmcid: 2732390 doi: 10.1101/gad.1652708
Nilsson, M. et al. Padlock probes: circularizing oligonucleotides for localized DNA detection. Science 265, 2085–2088 (1994).
pubmed: 7522346 doi: 10.1126/science.7522346
Figueiredo, J. et al. The importance of E-cadherin binding partners to evaluate the pathogenicity of E-cadherin missense mutations associated to HDGC. Eur. J. Hum. Genet. 21, 301–309 (2013).
pubmed: 22850631 doi: 10.1038/ejhg.2012.159
Liarte, S., Bernabé-García, Á. & Nicolás, F. J. Role of TGF-β in skin chronic wounds: a keratinocyte perspective. Cells 9, 306 (2020).
pubmed: 32012802 pmcid: 7072438 doi: 10.3390/cells9020306
Prokocimer, M. et al. Nuclear lamins: key regulators of nuclear structure and activities. J. Cell. Mol. Med. 13, 1059–1085 (2009).
pubmed: 19210577 pmcid: 4496104 doi: 10.1111/j.1582-4934.2008.00676.x
Gruenbaum, Y. & Medalia, O. Lamins: the structure and protein complexes. Curr. Opin. Cell Biol. 32, 7–12 (2015).
pubmed: 25460776 doi: 10.1016/j.ceb.2014.09.009
Wilson, K. L. & Foisner, R. Lamin-binding proteins. Cold Spring Harb. Perspect. Biol. 2, a000554 (2010).
Nastały, P. et al. Role of the nuclear membrane protein Emerin in front-rear polarity of the nucleus. Nat. Commun. 11, 2122 (2020).
Yang, L., Gal, J., Chen, J. & Zhu, H. Self-assembled FUS binds active chromatin and regulates gene transcription. Proc. Natl Acad. Sci. USA 111, 17809–17814 (2014).
pubmed: 25453086 pmcid: 4273402 doi: 10.1073/pnas.1414004111
Frasconi, M. et al. Interaction of ERp57 with calreticulin: Analysis of complex formation and effects of vancomycin. Biophys. Chem. 160, 46–53 (2012).
pubmed: 21996511 doi: 10.1016/j.bpc.2011.09.003
Ellgaard, L. & Frickel, E.-M. Calnexin, calreticulin, and ERp57: teammates in glycoprotein folding. Cell Biochem. Biophys. 39, 223–248 (2003).
pubmed: 14716078 doi: 10.1385/CBB:39:3:223
Guo, G. G. et al. Association of the chaperone glucose-regulated protein 58 (GRP58/ER-60/ERp57) with Stat3 in cytosol and plasma membrane complexes. J. Interf. Cytokine Res. 22, 555–563 (2002).
doi: 10.1089/10799900252982034
Coppari, S. et al. Nuclear localization and DNA interaction of protein disulfide isomerase ERp57 in mammalian cells. J. Cell. Biochem. 85, 325–333 (2002).
pubmed: 11948688 doi: 10.1002/jcb.10137
Afshar, N., Black, B. E. & Paschal, B. M. Retrotranslocation of the chaperone calreticulin from the endoplasmic reticulum lumen to the cytosol. Mol. Cell. Biol. 25, 8844–8853 (2005).
pubmed: 16199864 pmcid: 1265792 doi: 10.1128/MCB.25.20.8844-8853.2005
Dedhar, S. et al. Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367, 480–483 (1994).
pubmed: 8107809 doi: 10.1038/367480a0
Holaska, J. M. et al. Calreticulin is a receptor for nuclear export. J. Cell Biol. 152, 127–140 (2001).
pubmed: 11149926 pmcid: 2193655 doi: 10.1083/jcb.152.1.127
José Lasarte, J. et al. Integrins and ERp57 coordinate to regulate cell surface calreticulin in immunogenic Cell Death. Front. Oncol. 1, 411 (2019).
Heldin, C.-H., Lennartsson, J. & Westermark, B. Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis. J. Intern. Med. 283, 16–44 (2018).
pubmed: 28940884 doi: 10.1111/joim.12690
Wang, Y., Pennock, S. D., Chen, X., Kazlauskas, A. & Wang, Z. Platelet-derived growth factor receptor-mediated signal transduction from endosomes. J. Biol. Chem. 279, 8038–8046 (2004).
pubmed: 14660565 doi: 10.1074/jbc.M311494200
Sorkin, A. & von Zastrow, M. Endocytosis and signalling: intertwining molecular networks. Nat. Rev. Mol. Cell Biol. 10, 609–622 (2009).
pubmed: 19696798 pmcid: 2895425 doi: 10.1038/nrm2748
Heldin, J. et al. Dynamin inhibitors impair platelet-derived growth factor β-receptor dimerization and signaling. Exp. Cell Res. 380, 69–79 (2019).
pubmed: 30970237 doi: 10.1016/j.yexcr.2019.04.004
Wang, W. et al. Angiotensin-converting enzyme 2 metabolizes and partially inactivates Pyr-Apelin-13 and Apelin-17: physiological effects in the cardiovascular system. Hypertension 68, 365–377 (2016).
pubmed: 27217402 doi: 10.1161/HYPERTENSIONAHA.115.06892
Ni, W. et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Critical Care 24, 422 (2020).
Donoghue, M. et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ. Res. 87, E1-9 (2000).
Ziegler, C. G. K. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016–1035.e19 (2020).
pubmed: 32413319 pmcid: 7252096 doi: 10.1016/j.cell.2020.04.035
Heurich, A. et al. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J. Virol. 88, 1293–1307 (2014).
pubmed: 24227843 pmcid: 3911672 doi: 10.1128/JVI.02202-13
Dobreva, G. et al. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125, 971–986 (2006).
pubmed: 16751105 doi: 10.1016/j.cell.2006.05.012
Weichert, W. et al. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo. Clin. Cancer Res. 14, 1669–1677 (2008).
pubmed: 18347167 doi: 10.1158/1078-0432.CCR-07-0990
Dovey, O. M., Foster, C. T. & Cowley, S. M. Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc. Natl Acad. Sci. USA 107, 8242–8247 (2010).
pubmed: 20404188 pmcid: 2889513 doi: 10.1073/pnas.1000478107
Mansour, M. A. et al. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling. FEBS J. 282, 1394–1405 (2015).
pubmed: 25662172 doi: 10.1111/febs.13227
Gyorgy, A. B., Szemes, M., De Juan Romero, C., Tarabykin, V. & Agoston, D. V. SATB2 interacts with chromatin-remodeling molecules in differentiating cortical neurons. Eur. J. Neurosci. 27, 865–873 (2008).
pubmed: 18333962 doi: 10.1111/j.1460-9568.2008.06061.x
Shao, L. W. et al. Histone deacetylase HDA-1 modulates mitochondrial stress response and longevity. Nat. Commun. 11, 1–12 (2020).
doi: 10.1038/s41467-020-18501-w
Ikushima, H. & Miyazono, K. TGFβ signalling: a complex web in cancer progression. Nat. Rev. Cancer 10, 415–424 (2010).
pubmed: 20495575 doi: 10.1038/nrc2853
Jang, M. et al. Increased extracellular matrix density disrupts E-cadherin/β-catenin complex in gastric cancer cells. Biomater. Sci. 6, 2704 (2018).
pubmed: 30151505 doi: 10.1039/C8BM00843D
Andersson, S. et al. Insufficient antibody validation challenges oestrogen receptor beta research. Nat. Commun. 8, 15840 (2017).
Francés-Soriano, L. et al. In situ rolling circle amplification förster resonance energy transfer (RCA-FRET) for washing-free real-time single-protein imaging. Anal. Chem. 93, 1842–1850 (2021).
pubmed: 33356162 doi: 10.1021/acs.analchem.0c04828
Zadeh, J. N. et al. Software news and updates NUPACK: analysis and design of nucleic acid systems. J. Comput. Chem. 32, 170–173 (2011).
pubmed: 20645303 doi: 10.1002/jcc.21596
Kamentsky, L. et al. Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software. Bioinformatics 27, 1179–1180 (2011).
pubmed: 21349861 pmcid: 3072555 doi: 10.1093/bioinformatics/btr095
Raykova, D. et al. A method for Boolean analysis of protein interactions at a molecular level. Zenodo https://doi.org/10.5281/zenodo.6844631 (2022).
Raykova, D. et al. A method for Boolean analysis of protein interactions at a molecular level. Zenodo https://doi.org/10.5281/zenodo.6923187 (2022).

Auteurs

Doroteya Raykova (D)

Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical center, SE-751 24, Uppsala, Sweden. doroteya.raykova@farmbio.uu.se.

Despoina Kermpatsou (D)

Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical center, SE-751 24, Uppsala, Sweden.

Tony Malmqvist (T)

Atlas Antibodies AB, Bromma, Sweden.

Philip J Harrison (PJ)

Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical center, SE-751 24, Uppsala, Sweden.

Marie Rubin Sander (MR)

Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical center, SE-751 24, Uppsala, Sweden.

Christiane Stiller (C)

Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical center, SE-751 24, Uppsala, Sweden.

Johan Heldin (J)

Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical center, SE-751 24, Uppsala, Sweden.

Mattias Leino (M)

Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical center, SE-751 24, Uppsala, Sweden.

Sara Ricardo (S)

Faculty of Medicine, University of Porto, Porto, Portugal.
Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto/Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal.
Department of Sciences, University Institute of Health Sciences (IUCS), CESPU, Gandra, Portugal.

Anna Klemm (A)

Vi2, Department of Information Technology and SciLifeLab BioImage Informatics Facility, Uppsala University, Uppsala, Sweden.

Leonor David (L)

Faculty of Medicine, University of Porto, Porto, Portugal.
Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto/Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal.

Ola Spjuth (O)

Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical center, SE-751 24, Uppsala, Sweden.

Kalyani Vemuri (K)

Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden.

Anna Dimberg (A)

Department of Immunology, Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden.

Anders Sundqvist (A)

Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical center, SE-751 24, Uppsala, Sweden.

Maria Norlin (M)

Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical center, SE-751 24, Uppsala, Sweden.

Axel Klaesson (A)

Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical center, SE-751 24, Uppsala, Sweden.

Caroline Kampf (C)

Atlas Antibodies AB, Bromma, Sweden.

Ola Söderberg (O)

Department of Pharmaceutical Biosciences, Science for Life Laboratory, Uppsala University, Biomedical center, SE-751 24, Uppsala, Sweden. ola.soderberg@farmbio.uu.se.

Articles similaires

Databases, Protein Protein Domains Protein Folding Proteins Deep Learning

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Lung India Sheep Transcriptome

Calcineurin inhibition enhances

Priyanka Das, Alejandro Aballay, Jogender Singh
1.00
Animals Caenorhabditis elegans Longevity Caenorhabditis elegans Proteins Calcineurin

Classifications MeSH